Peleva, E <br/><br/>
Risk of cancer in patients with psoriasis on biological therapies: a systematic review.  [electronic resource] 

 -  The British journal of dermatology  01 2018 
 - 103-113 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.15830  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--adverse effects<br/>Adult<br/>Biological Products--adverse effects<br/>Dermatologic Agents--adverse effects<br/>Epidemiologic Methods<br/>Etanercept--adverse effects<br/>Female<br/>Humans<br/>Infliximab--adverse effects<br/>Male<br/>Middle Aged<br/>Neoplasms--chemically induced<br/>Psoriasis--drug therapy<br/>Risk Factors<br/>Ustekinumab--adverse effects